Phibro Animal Health PAHC
NASDAQ PAHC
$36.80 -0.51 (-1.37%)
As of: Sep 9, 2026 · 3:59 PM EDT

Phibro Animal Health (PAHC) Receivables - Other (2013 - 2026)

Phibro Animal Health (PAHC) posted Receivables - Other of $11.7 million for Q2 2026, up 118.69% on a QoQ basis from $5.4 million in Q1 2014.

Analysis

Phibro Animal Health (PAHC) Receivables - Other (2013 - 2026) Analysis & Trends

Phibro Animal Health has reported Receivables - Other for 3 years, with the latest figure at $11.7 million in Q2 2026.

  • On a quarterly basis, Receivables - Other changed N/A year-over-year to $11.7 million in Q2 2026; TTM through Jun 2026 was $11.7 million, a N/A change from a year earlier, with the FY2026 full-year figure at $11.7 million, changed N/A from the prior year.
  • Receivables - Other was $11.7 million for Q2 2026 at Phibro Animal Health, up from $5.4 million in the prior quarter.
  • The five-year high for Receivables - Other was $11.7 million in Q2 2026, with the low at $11.7 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.70 Mn
Mar 31, 2014 5.35 Mn
Jun 30, 2013 5.35 Mn